Advertisement

Index by author

December 01, 1991; Volume 40,Issue 6

A

  1. Aksoy, S

    1. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
      M McKinney, J H Miller, V A Gibson, L Nickelson and S Aksoy
      Molecular Pharmacology December 1991, 40 (6) 1014-1022;

  2. Allen, J M

    1. Decreased beta 2-adrenergic receptor mRNA expression in receptor-deficient S49 lymphoma cells.
      R J Hughes, M J Howard, J M Allen and P A Insel
      Molecular Pharmacology December 1991, 40 (6) 974-979;

B

  1. Baden, D G

    1. Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
      V L Trainer, W J Thomsen, W A Catterall and D G Baden
      Molecular Pharmacology December 1991, 40 (6) 988-994;

  2. Blaustein, M P

    1. Polypeptide toxins from the venoms of Old World and New World scorpions preferentially block different potassium channels.
      M P Blaustein, R S Rogowski, M J Schneider and B K Krueger
      Molecular Pharmacology December 1991, 40 (6) 932-942;

  3. Branchek, T A

    1. Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;

  4. Buxton, I L

    1. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
      L B Zhang, B Horowitz and I L Buxton
      Molecular Pharmacology December 1991, 40 (6) 943-951;
    2. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.
      L B Zhang and I L Buxton
      Molecular Pharmacology December 1991, 40 (6) 952-959;

C

  1. Campillo, M

    1. Theoretical studies on the histamine H2 receptor: construction of a receptor model based on the structural properties of dimaprit and N alpha-guanylhistamine.
      L Pardo, J Giraldo, M Martín and M Campillo
      Molecular Pharmacology December 1991, 40 (6) 980-987;

  2. Cardozo, M G

    1. Molecular mechanics and molecular dynamics studies of the intercalation of dynemicin-A with oligonucleotide models of DNA.
      M G Cardozo and A J Hopfinger
      Molecular Pharmacology December 1991, 40 (6) 1023-1028;

  3. Catterall, W A

    1. Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
      V L Trainer, W J Thomsen, W A Catterall and D G Baden
      Molecular Pharmacology December 1991, 40 (6) 988-994;

  4. Chaudhry, A

    1. Molecular cloning and expression of the rat beta 3-adrenergic receptor.
      J G Granneman, K N Lahners and A Chaudhry
      Molecular Pharmacology December 1991, 40 (6) 895-899;

  5. Cornwell, T L

    1. Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
      T L Cornwell, K B Pryzwansky, T A Wyatt and T M Lincoln
      Molecular Pharmacology December 1991, 40 (6) 923-931;

D

  1. De Léan, A

    1. Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.
      J Féthière and A De Léan
      Molecular Pharmacology December 1991, 40 (6) 915-922;

  2. Duman, R S

    1. Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;

E

  1. Eskuri, S

    1. Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
      J C Sill, C Uhl, S Eskuri, R Van Dyke and J Tarara
      Molecular Pharmacology December 1991, 40 (6) 1006-1013;

F

  1. Féthière, J

    1. Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.
      J Féthière and A De Léan
      Molecular Pharmacology December 1991, 40 (6) 915-922;

G

  1. Gee, K W

    1. Gamma-aminobutyric acidA receptor complexes in rat frontal cortex and spinal cord show differential responses to steroid modulation.
      K W Gee and N C Lan
      Molecular Pharmacology December 1991, 40 (6) 995-999;

  2. Gibson, V A

    1. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
      M McKinney, J H Miller, V A Gibson, L Nickelson and S Aksoy
      Molecular Pharmacology December 1991, 40 (6) 1014-1022;

  3. Giraldo, J

    1. Theoretical studies on the histamine H2 receptor: construction of a receptor model based on the structural properties of dimaprit and N alpha-guanylhistamine.
      L Pardo, J Giraldo, M Martín and M Campillo
      Molecular Pharmacology December 1991, 40 (6) 980-987;

  4. Graham, R M

    1. Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA.
      D M Perez, M T Piascik and R M Graham
      Molecular Pharmacology December 1991, 40 (6) 876-883;

  5. Granneman, J G

    1. Molecular cloning and expression of the rat beta 3-adrenergic receptor.
      J G Granneman, K N Lahners and A Chaudhry
      Molecular Pharmacology December 1991, 40 (6) 895-899;

H

  1. Hartig, P R

    1. Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;

  2. Henderson, G

    1. Mu-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro.
      C Kennedy and G Henderson
      Molecular Pharmacology December 1991, 40 (6) 1000-1005;

  3. Hopfinger, A J

    1. Molecular mechanics and molecular dynamics studies of the intercalation of dynemicin-A with oligonucleotide models of DNA.
      M G Cardozo and A J Hopfinger
      Molecular Pharmacology December 1991, 40 (6) 1023-1028;

  4. Horowitz, B

    1. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
      L B Zhang, B Horowitz and I L Buxton
      Molecular Pharmacology December 1991, 40 (6) 943-951;

  5. Hosey, M M

    1. Subtype-specific antibodies for muscarinic cholinergic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes.
      C S Mayanil, R M Richardson and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 900-907;
    2. Subtype-specific antibodies for muscarinic cholinergic receptors. II. Studies with reconstituted chick heart receptors and the GTP-binding protein G(o).
      R M Richardson, C S Mayanil and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 908-914;

  6. Howard, M J

    1. Decreased beta 2-adrenergic receptor mRNA expression in receptor-deficient S49 lymphoma cells.
      R J Hughes, M J Howard, J M Allen and P A Insel
      Molecular Pharmacology December 1991, 40 (6) 974-979;

  7. Hughes, R J

    1. Decreased beta 2-adrenergic receptor mRNA expression in receptor-deficient S49 lymphoma cells.
      R J Hughes, M J Howard, J M Allen and P A Insel
      Molecular Pharmacology December 1991, 40 (6) 974-979;

I

  1. Imakura, Y

    1. Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds.
      H Sakurai, T Miki, Y Imakura, M Shibuya and K H Lee
      Molecular Pharmacology December 1991, 40 (6) 965-973;

  2. Insel, P A

    1. Decreased beta 2-adrenergic receptor mRNA expression in receptor-deficient S49 lymphoma cells.
      R J Hughes, M J Howard, J M Allen and P A Insel
      Molecular Pharmacology December 1991, 40 (6) 974-979;

K

  1. Kennedy, C

    1. Mu-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro.
      C Kennedy and G Henderson
      Molecular Pharmacology December 1991, 40 (6) 1000-1005;

  2. Krueger, B K

    1. Polypeptide toxins from the venoms of Old World and New World scorpions preferentially block different potassium channels.
      M P Blaustein, R S Rogowski, M J Schneider and B K Krueger
      Molecular Pharmacology December 1991, 40 (6) 932-942;

L

  1. Lahners, K N

    1. Molecular cloning and expression of the rat beta 3-adrenergic receptor.
      J G Granneman, K N Lahners and A Chaudhry
      Molecular Pharmacology December 1991, 40 (6) 895-899;

  2. Lan, N C

    1. Gamma-aminobutyric acidA receptor complexes in rat frontal cortex and spinal cord show differential responses to steroid modulation.
      K W Gee and N C Lan
      Molecular Pharmacology December 1991, 40 (6) 995-999;

  3. Lee, K H

    1. Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds.
      H Sakurai, T Miki, Y Imakura, M Shibuya and K H Lee
      Molecular Pharmacology December 1991, 40 (6) 965-973;

  4. Lincoln, T M

    1. Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
      T L Cornwell, K B Pryzwansky, T A Wyatt and T M Lincoln
      Molecular Pharmacology December 1991, 40 (6) 923-931;

M

  1. Macchi, M

    1. Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;

  2. Martín, M

    1. Theoretical studies on the histamine H2 receptor: construction of a receptor model based on the structural properties of dimaprit and N alpha-guanylhistamine.
      L Pardo, J Giraldo, M Martín and M Campillo
      Molecular Pharmacology December 1991, 40 (6) 980-987;

  3. Mayanil, C S

    1. Subtype-specific antibodies for muscarinic cholinergic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes.
      C S Mayanil, R M Richardson and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 900-907;
    2. Subtype-specific antibodies for muscarinic cholinergic receptors. II. Studies with reconstituted chick heart receptors and the GTP-binding protein G(o).
      R M Richardson, C S Mayanil and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 908-914;

  4. McKinney, M

    1. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
      M McKinney, J H Miller, V A Gibson, L Nickelson and S Aksoy
      Molecular Pharmacology December 1991, 40 (6) 1014-1022;

  5. Meeley, M P

    1. Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells.
      S Regunathan, M P Meeley and D J Reis
      Molecular Pharmacology December 1991, 40 (6) 884-888;

  6. Miki, T

    1. Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds.
      H Sakurai, T Miki, Y Imakura, M Shibuya and K H Lee
      Molecular Pharmacology December 1991, 40 (6) 965-973;

  7. Miller, J H

    1. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
      M McKinney, J H Miller, V A Gibson, L Nickelson and S Aksoy
      Molecular Pharmacology December 1991, 40 (6) 1014-1022;

N

  1. Narasimhan, T R

    1. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C nuclear magnetic resonance spectroscopy studies.
      T R Narasimhan, S Safe, H J Williams and A I Scott
      Molecular Pharmacology December 1991, 40 (6) 1029-1035;

  2. Near, J A

    1. Purification of a [3H]dihydrotetrabenazine-binding protein from bovine adrenal medulla.
      M S Vincent and J A Near
      Molecular Pharmacology December 1991, 40 (6) 889-894;

  3. Nestler, E J

    1. Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;

  4. Nickelson, L

    1. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
      M McKinney, J H Miller, V A Gibson, L Nickelson and S Aksoy
      Molecular Pharmacology December 1991, 40 (6) 1014-1022;

P

  1. Pardo, L

    1. Theoretical studies on the histamine H2 receptor: construction of a receptor model based on the structural properties of dimaprit and N alpha-guanylhistamine.
      L Pardo, J Giraldo, M Martín and M Campillo
      Molecular Pharmacology December 1991, 40 (6) 980-987;

  2. Perez, D M

    1. Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA.
      D M Perez, M T Piascik and R M Graham
      Molecular Pharmacology December 1991, 40 (6) 876-883;

  3. Piascik, M T

    1. Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA.
      D M Perez, M T Piascik and R M Graham
      Molecular Pharmacology December 1991, 40 (6) 876-883;

  4. Pryzwansky, K B

    1. Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
      T L Cornwell, K B Pryzwansky, T A Wyatt and T M Lincoln
      Molecular Pharmacology December 1991, 40 (6) 923-931;

R

  1. Regunathan, S

    1. Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells.
      S Regunathan, M P Meeley and D J Reis
      Molecular Pharmacology December 1991, 40 (6) 884-888;

  2. Reis, D J

    1. Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells.
      S Regunathan, M P Meeley and D J Reis
      Molecular Pharmacology December 1991, 40 (6) 884-888;

  3. Richardson, R M

    1. Subtype-specific antibodies for muscarinic cholinergic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes.
      C S Mayanil, R M Richardson and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 900-907;
    2. Subtype-specific antibodies for muscarinic cholinergic receptors. II. Studies with reconstituted chick heart receptors and the GTP-binding protein G(o).
      R M Richardson, C S Mayanil and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 908-914;

  4. Rimland, J

    1. Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;

  5. Rogowski, R S

    1. Polypeptide toxins from the venoms of Old World and New World scorpions preferentially block different potassium channels.
      M P Blaustein, R S Rogowski, M J Schneider and B K Krueger
      Molecular Pharmacology December 1991, 40 (6) 932-942;

S

  1. Safe, S

    1. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C nuclear magnetic resonance spectroscopy studies.
      T R Narasimhan, S Safe, H J Williams and A I Scott
      Molecular Pharmacology December 1991, 40 (6) 1029-1035;

  2. Saijoh, K

    1. Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;

  3. Sakurai, H

    1. Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds.
      H Sakurai, T Miki, Y Imakura, M Shibuya and K H Lee
      Molecular Pharmacology December 1991, 40 (6) 965-973;

  4. Schechter, L E

    1. Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;

  5. Schneider, M J

    1. Polypeptide toxins from the venoms of Old World and New World scorpions preferentially block different potassium channels.
      M P Blaustein, R S Rogowski, M J Schneider and B K Krueger
      Molecular Pharmacology December 1991, 40 (6) 932-942;

  6. Scott, A I

    1. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C nuclear magnetic resonance spectroscopy studies.
      T R Narasimhan, S Safe, H J Williams and A I Scott
      Molecular Pharmacology December 1991, 40 (6) 1029-1035;

  7. Shibuya, M

    1. Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds.
      H Sakurai, T Miki, Y Imakura, M Shibuya and K H Lee
      Molecular Pharmacology December 1991, 40 (6) 965-973;

  8. Sill, J C

    1. Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
      J C Sill, C Uhl, S Eskuri, R Van Dyke and J Tarara
      Molecular Pharmacology December 1991, 40 (6) 1006-1013;

  9. Sweetnam, P

    1. Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;

T

  1. Tarara, J

    1. Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
      J C Sill, C Uhl, S Eskuri, R Van Dyke and J Tarara
      Molecular Pharmacology December 1991, 40 (6) 1006-1013;

  2. Thomsen, W J

    1. Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
      V L Trainer, W J Thomsen, W A Catterall and D G Baden
      Molecular Pharmacology December 1991, 40 (6) 988-994;

  3. Trainer, V L

    1. Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
      V L Trainer, W J Thomsen, W A Catterall and D G Baden
      Molecular Pharmacology December 1991, 40 (6) 988-994;

U

  1. Uhl, C

    1. Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
      J C Sill, C Uhl, S Eskuri, R Van Dyke and J Tarara
      Molecular Pharmacology December 1991, 40 (6) 1006-1013;

V

  1. Van Dyke, R

    1. Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
      J C Sill, C Uhl, S Eskuri, R Van Dyke and J Tarara
      Molecular Pharmacology December 1991, 40 (6) 1006-1013;

  2. Vincent, M S

    1. Purification of a [3H]dihydrotetrabenazine-binding protein from bovine adrenal medulla.
      M S Vincent and J A Near
      Molecular Pharmacology December 1991, 40 (6) 889-894;

W

  1. Wadler, S

    1. Reversal of doxorubicin resistance by hydrophobic, but not hydrophilic, forskolins.
      S Wadler and C P Yang
      Molecular Pharmacology December 1991, 40 (6) 960-964;

  2. Weinshank, R L

    1. Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;

  3. Williams, H J

    1. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C nuclear magnetic resonance spectroscopy studies.
      T R Narasimhan, S Safe, H J Williams and A I Scott
      Molecular Pharmacology December 1991, 40 (6) 1029-1035;

  4. Wyatt, T A

    1. Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
      T L Cornwell, K B Pryzwansky, T A Wyatt and T M Lincoln
      Molecular Pharmacology December 1991, 40 (6) 923-931;

X

  1. Xin, W

    1. Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;

Y

  1. Yang, C P

    1. Reversal of doxorubicin resistance by hydrophobic, but not hydrophilic, forskolins.
      S Wadler and C P Yang
      Molecular Pharmacology December 1991, 40 (6) 960-964;

Z

  1. Zgombick, J M

    1. Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;

  2. Zhang, L B

    1. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
      L B Zhang, B Horowitz and I L Buxton
      Molecular Pharmacology December 1991, 40 (6) 943-951;
    2. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.
      L B Zhang and I L Buxton
      Molecular Pharmacology December 1991, 40 (6) 952-959;
Back to top

In this issue

Advertisement